1. Nash T.G., Cheever A.N., Ottensen E.A., Cook J.A. (1982): Schistosomal infections in man: perspective and recent findings. Ann. Int. Med., 97, 740–754.
2. Daneshmend T.K., Homeida M. (1983): The pharmacokinetics of oxamniquine in advanced hepatosplenic schistosomiasis. Br. J. Clin. Pharmacol., 15, 611P.
3. Massoud A., Hafez A.S., Hussein M.M., Abdel Karim A.H., El Nahaal A. (1984): Pharmacokinetic studies on praziquantel and oxamniquine in intestinal schistosomiasis. J. Egypt. Soc. Parasitol. 14, 599–608.
4. Kokwaro G.O., Taylor G. (1991): Oxamniquine pharmacokinetics in healthy Kenyan volunteers. E. Afr. Med. J., 69, 456–461.
5. Woolhouse N.M., Kaye B., Parke D.V. (1979): Species differences in N-dealkylation of oxamniquine. Xenobiotica, 9, 323–332.